Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

156.17
-1.3000-0.83%
Volume:3.51M
Turnover:551.30M
Market Cap:376.35B
PE:17.38
High:158.23
Open:157.73
Low:155.49
Close:157.47
Loading ...

Johnson & Johnson to Present Latest Trial Data for TAR-200 to Treat Bladder Cancer

MT Newswires Live
·
Yesterday

Is Johnson & Johnson (JNJ) the Best American Dividend Stock to Buy According to Analysts?

Insider Monkey
·
Yesterday

Johnson & Johnson announces new data from oncology pipeline at AUA meeting

TIPRANKS
·
Yesterday

Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges

Zacks
·
Yesterday

J&J : Guggenheim Cuts Target Price to $164 From $166

THOMSON REUTERS
·
Yesterday

Guggenheim Adjusts Price Target on Johnson & Johnson to $164 From $166, Keeps Neutral Rating

MT Newswires Live
·
Yesterday

Is Johnson & Johnson (JNJ) the Best Low Volatility Stock to Buy Now?

Insider Monkey
·
20 Apr

3 Top Dividend Stocks Yielding Over 3% to Buy With $500 Right Now

Motley Fool
·
19 Apr

U.S. Weekly Review|Stock Market Tumbles On Nvidia Export Curbs, Fed Chief Powell, UnitedHealth

Investor’s Business Daily
·
19 Apr

Johnson & Johnson Pivots Its AI Strategy -- WSJ

Dow Jones
·
18 Apr

How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock

Benzinga
·
18 Apr

UnitedHealth Woes Aren't Dragging Down the Entire Sector. Here's Why. -- Barrons.com

Dow Jones
·
18 Apr

Johnson & Johnson Is Maintained at Equal-Weight by Barclays

Dow Jones
·
17 Apr

Johnson & Johnson (JNJ): Among the Innovative Healthcare Stocks to Watch in 2025

Insider Monkey
·
17 Apr

Pharma Stock Roundup: J&J's Q1 Results, PFE's Obesity Setback

Zacks
·
17 Apr

Here's How You Should Play JNJ Stock After Q1 Earnings Beat

Zacks
·
17 Apr

Netflix stock has been nearly unscathed by Trump tariffs. Some think it could be Silicon Valley’s version of Johnson & Johnson

Fortune
·
17 Apr

Addex Reclaims Rights to Epilepsy Drug as Janssen Ends Partnership

MT Newswires Live
·
17 Apr

4 Reasons Johnson & Johnson Could Be the Perfect Stock to Own in Today's Turbulent Market

Motley Fool
·
17 Apr

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149

GlobeNewswire
·
17 Apr